Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by SEIDEMAN, P.
Right arrow Articles by MELANDER, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SEIDEMAN, P.
Right arrow Articles by MELANDER, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1988 British Society for Rheumatology

brief-report

EQUIANALGESIC EFFECTS OF PARACETAMOL AND INDOMETHACIN IN RHEUMATOID ARTHRITIS

P. SEIDEMAN1,3 and A. MELANDER2

1Department of Rheumatology, The Karolinska Institute Karolinska Hospital, Stockholm
2Division of Clinical Pharmacology, Lund University Health Sciences Centre Dalby, Sweden

Correspondence to: 3Address correspondence to Dr. Peter Seideman, Department of Internal Medicine, Div. of Rheumatology, Danderyd Hospital, S-182 88 Danderyd, Sweden.

The therapeutic and adverse effects of 2 weeks of treatment with high-dose indomethacin (150 mg/day) were compared with those of low-dose indomethacin (50 mg/day) combined with paracetamol (4 g/day) in a double-blind, double-dummy, cross-over study in 17 patients with active rheumatoid arthritis. Grip strength, Ritchie's index, joint circumference, joint pain, and patient's and physician's global assessments were estimated, and conventional laboratory parameters were followed. In addition, the time-concentration profiles of indomethacin and paracetamol were assessed during steady state. All patients had measurable plasma drug levels, indicating adequate compliance, and responders and nonresponders (five on each treatment) had equal drug levels, indicating that the variation in therapeutic efficacy was not secondary to pharmacokinetic differences. While there were fewer and milder side-effects during treatment with the drug combination, there was no difference in therapeutic efficacy. Hence, it appears that the main therapeutic profit of indomethacin in daily doses greater than 50 mg is enhanced analgesia. As such dosage involves pronounced side-effects, it seems more appropriate to employ the combination of 50 mg indomethacin and 4 g paracetamol, whereby similar analgesia can be obtained without an increase in side-effects.

KEY WORDS: Rheumatoid arthritis, Analgesia, Paracetamol, Indomethacin, Plasma levels.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JAMAHome page
P. B. Watkins, N. Kaplowitz, J. T. Slattery, C. R. Colonese, S. V. Colucci, P. W. Stewart, and S. C. Harris
Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial.
JAMA, July 5, 2006; 296(1): 87 - 93.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
M. Hyllested, S. Jones, J. L. Pedersen, and H. Kehlet
Comparative effect of paracetamol, NSAIDs or their combination in postoperative pain management: a qualitative review
Br. J. Anaesth., February 1, 2002; 88(2): 199 - 214.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.